- Home
- SNTI vs JVA Comparison
SNTI vs JVA Comparison
Compare SNTI & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- JVA
- Stock Information
- Founded
- SNTI 2016
- JVA 1971
- Country
- SNTI United States
- JVA United States
- Employees
- SNTI N/A
- JVA N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- JVA Packaged Foods
- Sector
- SNTI Health Care
- JVA Consumer Staples
- Exchange
- SNTI Nasdaq
- JVA Nasdaq
- Market Cap
- SNTI 14.1M
- JVA 14.7M
- IPO Year
- SNTI N/A
- JVA 2005
- Fundamental
- Price
- SNTI $2.38
- JVA $2.75
- Analyst Decision
- SNTI
- JVA
- Analyst Count
- SNTI 0
- JVA 0
- Target Price
- SNTI N/A
- JVA N/A
- AVG Volume (30 Days)
- SNTI 20.3K
- JVA 179.0K
- Earning Date
- SNTI 11-11-2024
- JVA 10-18-2024
- Dividend Yield
- SNTI N/A
- JVA N/A
- EPS Growth
- SNTI N/A
- JVA N/A
- EPS
- SNTI N/A
- JVA 0.20
- Revenue
- SNTI $338,000.00
- JVA $76,111,698.00
- Revenue This Year
- SNTI $254.47
- JVA N/A
- Revenue Next Year
- SNTI $169.66
- JVA N/A
- P/E Ratio
- SNTI N/A
- JVA $14.73
- Revenue Growth
- SNTI N/A
- JVA 17.27
- 52 Week Low
- SNTI $1.52
- JVA $0.67
- 52 Week High
- SNTI $8.48
- JVA $3.88
- Technical
- Relative Strength Index (RSI)
- SNTI 40.25
- JVA 46.64
- Support Level
- SNTI $2.05
- JVA $3.00
- Resistance Level
- SNTI $2.48
- JVA $3.12
- Average True Range (ATR)
- SNTI 0.23
- JVA 0.25
- MACD
- SNTI -0.06
- JVA -0.08
- Stochastic Oscillator
- SNTI 17.34
- JVA 4.81
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.